Region: Mexico

Intellectual property on demand

Leading law firms consider how different governments might apply compulsory licensing in response to potential covid-19 breakthroughs

12 August 2020

How compulsory patent licensing could be used to combat covid-19 in the Americas

As the race to find coronavirus cures intensifies, we explore how legislation might be deployed in Brazil, Canada, Mexico and the US to ensure inventions are shared

05 August 2020

Regulatory framework – healthcare products and intellectual property in Mexico

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2020

With Mexico’s change of government, new trends and practices have been introduced, affecting, among other things, the regulatory and IP framework. This chapter contains an overview of the main ammendments made throughout 2019 and a brief discussion on what it is expected for 2020.

07 May 2020

Biologics exclusivity may be sacrificed to seal NAFTA 2.0 deal

Trump administration said to be considering weakening provisions to break political gridlock over USMCA

05 December 2019

What leaked US trade talks tell us about future of UK pharma IP

Secret government documents detailing pharma patent discussions between UK and US officials have stirred up a controversy in the run up to the British general election later this month

04 December 2019

Delays in patent granting and NAFTA regulation

Featured in IAM Yearbook: Building IP value in the 21st century 2020

03 October 2019

The how's and why's of shutting out patent infringers in the Americas

While injunctions are valuable instruments their availability varies widely around the world. In the first of a three-part analysis of the global landscape we focus on the three most populous countries in the Americas: the US, Mexico and Brazil

04 September 2019

Trespassing prohibited

The availability of injunctive relief varies widely around the world. In our first analysis of the global injunction landscape we lift the lid on which jurisdictions provide the best opportunity for a sales ban

30 August 2019

Regulating cannabis use in Mexico – current legal framework

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2019

Mexico’s current legislation regarding cannabis use is the result of several legal actions. More than five years ago, the first legal actions regarding the prohibition of cannabis use were filed by the authorities, pushing towards a specific legal framework.

13 May 2019

Life sciences innovators to gain from “new NAFTA”, but not immediately

The recently-struck deal promises to boost IP protection for pharma innovators in North America, but it will be years until it has an impact

08 October 2018